TEPROTUMUMAB
Teprotumumab 500 mg injection, 1 vial
TEPROTUMUMAB (15568J)
15568J
Manner of administration:Injection
Restriction
Indication: Active moderate to severe thyroid eye disease
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 3 | # of repeats: 0 | DPMQ: $31,992.27 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tepezza | |||||